CoChat

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases

Alijotas-Reig, Jaume, Esteve-Valverde, Enrique, Ferrer-Oliveras, Raquel, Sáez-Comet, Luis, Lefkou, Elmina, Mekinian, Arsène, Belizna, Cristina, Ruffatti, Amelia, Tincani, Angela, Marozio, Luca, Espinosa, Gerard, Cervera, Ricard, Ríos-Garcés, Roberto, De Carolis, Sara, Latino, Omar, LLurba, Elisa, Chighizola, Cecilia Beatrice, Gerosa, Maria, Pengo, Vittorio, Lundelin, Krista, Rovere-Querini, Patrizia, Canti, Valentina, Mayer-Pickel, Karoline, Reshetnyak, Tatiana, Hoxha, Ariela, Tabacco, Sara, Stojanovich, Ldjumila, Gogou, Vassiliki, Varoudis, Aikaterini, Arnau, Anna, Ruiz-Hidalgo, Domingo, Trapé, Jaume, Sos, Laia, Stoppani, Carlotta, Martí-Cañamares, Anna, Farran-Codina, Inmaculada · 2019 · Autoimmunity Reviews
Cited by 211

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

AIM To analyse the clinical features, laboratory data and foetal-maternal outcomes, and follow them up on a cohort of 1000 women with obstetric antiphospholipid syndrome (OAPS). METHODS The European Registry of OAPS became a registry within the framework of the European Forum on Antiphospholipid Antibody projects and was placed on a website in June 2010. Thirty hospitals throughout Europe have collaborated to carry out this registry. Cases with obstetric complaints related to antiphospholipid antibodies (aPL) who tested positive for aPL at least twice were included prospectively and retrospectively. The seven-year survey results are reported. RESULTS 1000 women with 3553 episodes were included of which 2553 were historical and 1000 were latest episodes. All cases fulfilled the Sydney classification criteria. According to the laboratory categories, 292 (29.2%) were in category I, 357 (35.7%) in IIa, 224 (22.4%) in IIb and 127 (12.7%) in IIc. Miscarriages were the most prevalent clinical manifestation in 386 cases (38.6%). Moreover, the presence of early preeclampsia (PE) and early foetal growth restriction (FGR) appeared in 181 (18.1%) and 161 (16.1%), respectively. In this series, 448 (44.8%) women received the recommended OAPS treatment. Patients with recommended treatment had a good live-birth rate (85%), but worse results (72.4%) were obtained in patients with any treatment (low-dose aspirin (LDA) or low-molecular-weight heparin (LMWH) not on recommended schedule, while patients with no treatment showed a poor birth rate (49.6%). CONCLUSION In this series, recurrent miscarriage is the most frequent poor outcome. To avoid false-negative diagnoses, all laboratory category subsets were needed. OAPS cases have very good foetal-maternal outcomes when treated. Results suggest that we were able to improve our clinical practice to offer better treatment and outcomes to OAPS patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.autrev.2018.12.006

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 211

Metadata

Authors
Alijotas-Reig, J., Esteve-Valverde, E., Ferrer-Oliveras, R., Sáez-Comet, L., Lefkou, E., Mekinian, A., Belizna, C., Ruffatti, A., Tincani, A., Marozio, L., Espinosa, G., Cervera, R., Ríos-Garcés, R., De Carolis, S., Latino, O., LLurba, E., Chighizola, C. B., Gerosa, M., Pengo, V., Lundelin, K., Rovere-Querini, P., Canti, V., Mayer-Pickel, K., Reshetnyak, T., Hoxha, A., Tabacco, S., Stojanovich, L., Gogou, V., Varoudis, A., Arnau, A., Ruiz-Hidalgo, D., Trapé, J., Sos, L., Stoppani, C., Martí-Cañamares, A., & Farran-Codina, I.
Venue
Autoimmunity Reviews
Publisher
Elsevier BV
Published
2019-04
Volume
18
Issue
4
Pages
406-414
ISSN
1568-9972 (ISSN-L)
OpenAlex
W2040532865
Cited by
211
References
9
FWCI
13.76
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases. https://app.cochat.ai/papers/10.1016/j.autrev.2018.12.006
The paper
Alijotas-Reig, J., Esteve-Valverde, E., Ferrer-Oliveras, R., Sáez-Comet, L., Lefkou, E., Mekinian, A., Belizna, C., Ruffatti, A., Tincani, A., Marozio, L., Espinosa, G., Cervera, R., Ríos-Garcés, R., De Carolis, S., Latino, O., LLurba, E., Chighizola, C. B., Gerosa, M., Pengo, V., . . . Farran-Codina, I. (2019). The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases. Autoimmunity Reviews. https://doi.org/10.1016/j.autrev.2018.12.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.